Larry Robbins Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 months, 1 week ago
Larry Robbins has an estimated net worth of at least $935.9 million*, as of Oct. 29, 2025. They own 8.2 million shares of CVS stock. They have sold 3.8 million shares of CVS stock since 2021, for an estimated $253.7 million.
Larry Robbins $CVS SEC Form 4 Insider Trading
Larry Robbins has filed a total of 6 insider trades in $CVS since 2021. Their most recent trade was a sale of 1.7 million shares, made on May 02, 2025. Their largest trade was a sale of 1.7 million shares, made on May 02, 2025. We estimate that they now own 8.2 million shares of $CVS, worth an estimated $682.2 million.
Insider Trading at $CVS
There have been a total of 55 insider trades reported at $CVS since 2021, with 61,855 shares purchased and 4.8 million shares sold. The most active insider traders in $CVS stock have been Prem S Shah, Daniel P Finke, and Alan Lotvin. The most recent trade was a purchase of 24 shares reported by Steven H Nelson (EVP and President, Aetna), made on Jan 23, 2025.
History of Insider Stock Trades by Larry Robbins
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
BFLY
|
Purchase | 21,370 | Dec 11, 2025 | Dec. 15, 2025, 7:20 p.m. |
|
BFLY
|
Purchase | 821,648 | Dec 03, 2025 | Dec. 5, 2025, 6:40 p.m. |
|
BFLY
|
Purchase | 536,893 | Dec 04, 2025 | Dec. 5, 2025, 6:40 p.m. |
|
BFLY
|
Purchase | 200,000 | Dec 05, 2025 | Dec. 5, 2025, 6:40 p.m. |
|
BFLY
|
Purchase | 1.0 million | Nov 19, 2025 | Nov. 21, 2025, 6:35 p.m. |
|
BFLY
|
Purchase | 800,000 | Nov 21, 2025 | Nov. 21, 2025, 6:35 p.m. |
|
BFLY
|
Purchase | 1.0 million | Nov 20, 2025 | Nov. 21, 2025, 6:35 p.m. |
CVS
|
Sale | 1.7 million | May 02, 2025 | May 6, 2025, 4:15 p.m. |
|
CVS
|
Sale | 222,556 | May 02, 2025 | May 6, 2025, 4:15 p.m. |
|
CVS
|
Sale | 373,776 | May 02, 2025 | May 6, 2025, 4:15 p.m. |
|
CVS
|
Sale | 1.2 million | May 05, 2025 | May 6, 2025, 4:15 p.m. |
|
CVS
|
Sale | 96,999 | May 05, 2025 | May 6, 2025, 4:15 p.m. |
|
CVS
|
Sale | 150,000 | May 06, 2025 | May 6, 2025, 4:15 p.m. |
|
BFLY
|
Purchase | 244,774 | Aug 30, 2024 | Sept. 4, 2024, 4:34 p.m. |
|
BFLY
|
Purchase | 952,277 | Aug 28, 2024 | Aug. 30, 2024, 4:18 p.m. |
|
BFLY
|
Purchase | 294,673 | Aug 28, 2024 | Aug. 30, 2024, 4:18 p.m. |
|
BFLY
|
Purchase | 429,919 | Aug 29, 2024 | Aug. 30, 2024, 4:18 p.m. |
|
BFLY
|
Purchase | 500,000 | Mar 15, 2022 | March 14, 2022, 8 p.m. |
$CVS Executives and Stock Owners with Insider Trades
-
Prem S Shah, EVP and Co-President of Retail
-
Daniel P Finke, EVP/Pres, Health Care Benefits
-
Alan Lotvin, EVP&President-PharmacyServices
-
Thomas M Moriarty, EVP & General Counsel
-
Troyen A Brennan, EVP and Chief Medical Officer
-
James David Clark, SVP, Cont & Chief Acct Officer
-
Heidi B Capozzi, EVP and Chief People Officer
-
Jonathan C Roberts, EVP & Chief Operating Officer
-
Karen S Lynch, President and CEO
-
Prem S Shah, EVP and Pres-Pharm, Consumer W
-
Steven H Nelson, EVP and President, Aetna
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.